Pharmacokinetics and disposition of 3-deazauridine in humans. 1979

J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo

3-Deazauridine (3-DAU) pharmacology was studied in 20 patients who received the drug by rapid or continuous infusion. In 8 studies, the plasma clearance of 3-DAU after rapid administration was biphasic, with an average terminal t1/2 of 4.4 hr and an extrapolated volume of distribution of 0.57 liter/kg. After 5-day continuous infusion of 3-DAU, the plasma clearance was also biphasic, with an average terminal t1/2 of 21.3 hr and an extrapolated volume of distribution of 18.8 liter/kg. 2,4-Dihydroxypyridine, the aglycone of 3-DAU, was observed in plasma but not in urine of patients receiving the drug by rapid infusion. The urinary excretion of 3-DAU was low, only 7.8% 24 hr after rapid infusion and 7.2% up to 4 days after continuous infusion. Tissue distribution of 3-DAU was determined from autopsy samples of 2 patients. Not only were high levels of 3-DAU detected in the tissues studied, but 3-DAU triphosphate, the active metabolite of 3-DAU, was present in brain, lung, and liver.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D015092 3-Deazauridine 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. 4-Hydroxy-1-(beta-D-Ribopentofuranosyl)-2-Pyridone,3 Deazauridine

Related Publications

J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 1978, Drug metabolism and disposition: the biological fate of chemicals,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 1987, Journal of cardiovascular pharmacology,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
February 2008, Drug metabolism and disposition: the biological fate of chemicals,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 2010, Current medicinal chemistry,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
August 2010, Drug metabolism letters,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 2000, Drug metabolism and disposition: the biological fate of chemicals,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 1996, Drug metabolism and disposition: the biological fate of chemicals,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 1982, Cancer treatment reports,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
September 2005, Life sciences,
J A Benvenuto, and S W Hall, and D Farquhar, and D J Stewart, and R S Benjamin, and T L Loo
January 1992, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!